PFM Health Sciences, LP — 13F Holdings & Portfolio

CIK 1442756 · latest 13F-HR filed 2026-08-14

PFM Health Sciences, LP manages $1.17B in 13F-reported U.S. long-equity assets across 98 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are ASND (5.34%), AXSM (4.61%), LLY (4.04%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 33 new positions and exited 14; 40 existing positions rose in reported value and 20 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$1.17B

Long-equity book

Holdings
98

Distinct positions

Period
2026-06-30

Filed 2026-08-14

Q/Q Activity
+33 / −14 / ↑40 / ↓20

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q2 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q1 26 → Q2 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 34.3%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated Mar 31, 2026.

Assets Under Management
$1.27B
Discretionary
$1.27B
Employees
17
Accounts
7
Address
50 CALIFORNIA STREET
SUITE 2650
SAN FRANCISCO, CA 94111
Phone
(415) 281-1000
Name Title / Status Ownership Type
ALJOE, JONATHAN, JUDE ControlCHIEF FINANCIAL OFFICER
since Jun 2023
Less than 5%Individual
GROSSMAN, BRIAN, DAVID ControlLIMITED PARTNER, PORTFOLIO MANAGER
since Feb 2008
75% or moreIndividual
MOONEY, DARREN, WILLIAM ControlGENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER
since May 2023
Less than 5%Individual
PFM HEALTH SCIENCES GP LLC ControlGENERAL PARTNER
since Oct 2020
Less than 5%Domestic Entity
GROSSMAN, BRIAN, DAVID Control
Indirect owner via PFM HEALTH SCIENCES GP LLC
MANAGING MEMBER
since Oct 2020
75% or moreIndividual
Ownership & leadership changes · 13 filings with changes since Mar 30, 2012

From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.

Mar 31, 2026 filing
  • ChangedMOONEY, DARREN, WILLIAM · title CHIEF COMPLIANCE OFFICER AND COUNSEL → GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER
Mar 31, 2025 filing
  • ChangedMOONEY, DARREN, WILLIAM · title CHIEF COMPLIANCE OFFICER → CHIEF COMPLIANCE OFFICER AND COUNSEL
Jun 30, 2023 filing
  • No longer listedDUBORD, YUAN, SHI · LIMITED PARTNER, CFO · Less than 5% · control person · listed since Jul 2014
  • No longer listedSADOW, DARIN, SCOTT · LIMITED PARTNER, GENERAL COUNSEL, CCO · Less than 5% · control person · listed since Mar 2011
  • AddedALJOE, JONATHAN, JUDE · CHIEF FINANCIAL OFFICER · Less than 5% · control person
  • AddedMOONEY, DARREN, WILLIAM · CHIEF COMPLIANCE OFFICER · Less than 5% · control person
Nov 16, 2020 filing
  • No longer listedGROSSMAN, BRIAN, DAVID · M/M · 50–75% · indirect via PARTNER FUND MANAGEMENT GP, LLC · control person · listed since Jan 2016
  • No longer listedJAMES, CHRISTOPHER, MEDLOCK · LIMITED PARTNER, PORTFOLIO MANAGER, CO-MANAGING PARTNER · 50–75% · control person · listed since Feb 2008
  • No longer listedJAMES, CHRISTOPHER, MEDLOCK · M/M · 50–75% · indirect via PARTNER FUND MANAGEMENT GP, LLC · control person · listed since Feb 2008
  • No longer listedPARTNER FUND MANAGEMENT GP, LLC · GENERAL PARTNER, PARTNER FUND MANAGEMENT, L.P. · Less than 5% · control person · listed since Feb 2008
  • AddedGROSSMAN, BRIAN, DAVID · MANAGING MEMBER · 75% or more · indirect via PFM HEALTH SCIENCES GP LLC · control person
  • AddedPFM HEALTH SCIENCES GP LLC · GENERAL PARTNER · Less than 5% · control person
  • ChangedGROSSMAN, BRIAN, DAVID · title LIMITED PARTNER, PORTFOLIO MANAGER, CO-MANAGING PARTNER → LIMITED PARTNER, PORTFOLIO MANAGER; ownership 50–75% → 75% or more
Mar 31, 2020 filing
  • No longer listedGOODELL, WILLIAM, RICE · LIMITED PARTNER, PRESIDENT, COO · Less than 5% · control person · listed since Jun 2015
Mar 29, 2018 filing
  • No longer listedGROSSMAN, BRIAN, DAVID · M/M · 50–75% · indirect via PARTNER FUND MANAGEMENT GP, L.P.; PARTNER INVESTMENT MANAGEMENT GP, LLC; PARTNER ADVISORY SERVICES GP, LLC · control person · listed since Jan 2016
  • No longer listedJAMES, CHRISTOPHER, MEDLOCK · M/M · 50–75% · indirect via PARTNER FUND MANAGEMENT GP, L.P.; PARTNER INVESTMENT MANAGEMENT GP, LLC; PARTNER ADVISORY SERVICES GP, LLC · control person · listed since Feb 2008
  • No longer listedPARTNER ADVISORY SERVICES GP, LLC · GENERAL PARTNER, PARTNER ADVISORY SERVICES, L.P. · Less than 5% · control person · listed since Feb 2008
  • No longer listedPARTNER INVESTMENT MANAGEMENT GP, LLC · GENERAL PARTNER, PARTNER INVESTMENT MANAGEMENT, L.P. · Less than 5% · control person · listed since Feb 2008
  • AddedGROSSMAN, BRIAN, DAVID · M/M · 50–75% · indirect via PARTNER FUND MANAGEMENT GP, LLC · control person
  • AddedJAMES, CHRISTOPHER, MEDLOCK · M/M · 50–75% · indirect via PARTNER FUND MANAGEMENT GP, LLC · control person
Mar 30, 2017 filing
  • AddedGROSSMAN, BRIAN, DAVID · M/M · 50–75% · indirect via PARTNER FUND MANAGEMENT GP, L.P.; PARTNER INVESTMENT MANAGEMENT GP, LLC; PARTNER ADVISORY SERVICES GP, LLC · control person
  • ChangedGROSSMAN, BRIAN, DAVID · title LIMITED PARTNER, PORTFOLIO MANAGER → LIMITED PARTNER, PORTFOLIO MANAGER, CO-MANAGING PARTNER; ownership 10–25% → 50–75%
  • ChangedJAMES, CHRISTOPHER, MEDLOCK · title LIMITED PARTNER, CIO, PORTFOLIO MANAGER → LIMITED PARTNER, PORTFOLIO MANAGER, CO-MANAGING PARTNER
  • ChangedJAMES, CHRISTOPHER, MEDLOCK · indirect via PARTNER FUND MANAGEMENT GP, L.P.; PARTNER INVESTMENT MANAGEMENT GP, LLC; PARTNER ADVISORY SERVICES GP, LLC: ownership 75% or more → 50–75%
  • ChangedSADOW, DARIN, SCOTT · title LIMITED PARTNER, CCO → LIMITED PARTNER, GENERAL COUNSEL, CCO
Mar 30, 2016 filing
  • ChangedGOODELL, WILLIAM, RICE · title LIMITED PARTNER, COO → LIMITED PARTNER, PRESIDENT, COO
Jul 7, 2015 filing
  • AddedGOODELL, WILLIAM, RICE · LIMITED PARTNER, COO · Less than 5% · control person
  • ChangedGROSSMAN, BRIAN, DAVID · now a control person
  • ChangedSADOW, DARIN, SCOTT · now a control person
Mar 31, 2015 filing
  • No longer listedSEGURITAN, FREDERICK, ANTHONY · LIMITED PARTNER · 5–10% · listed since Feb 2008
  • No longer listedSUMME, KIMBERLY, ANNE · LIMITED PARTNER, COO, GENERAL COUNSEL · Less than 5% · listed since Jan 2011
Older changes (4 more filings)
Aug 1, 2014 filing
  • No longer listedMOORE, ERIC, TODD · LIMITED PARTNER, CFO · Less than 5% · control person · listed since Feb 2008
  • AddedDUBORD, YUAN, SHI · LIMITED PARTNER, CFO · Less than 5% · control person
Mar 31, 2014 filing
  • ChangedSADOW, DARIN, SCOTT · title CCO → LIMITED PARTNER, CCO
Jan 28, 2013 filing
  • No longer listedARISTIDES, CHRISTOPHER, GEORGE · LIMITED PARTNER, PORTFOLIO MANAGER · 10–25% · listed since Feb 2008
  • No longer listedBOUSABA, JOSEPH, NICOLAS · LIMITED PARTNER · 5–10% · listed since Feb 2008
  • No longer listedTARANTINO, KENN, RICHARD · LIMITED PARTNER · 5–10% · listed since Feb 2008
  • ChangedJAMES, CHRISTOPHER, MEDLOCK · ownership 25–50% → 50–75%
Mar 30, 2012 filing (earliest on record)
  • ListedARISTIDES, CHRISTOPHER, GEORGE · LIMITED PARTNER, PORTFOLIO MANAGER · 10–25%
  • ListedBOUSABA, JOSEPH, NICOLAS · LIMITED PARTNER · 5–10%
  • ListedGROSSMAN, BRIAN, DAVID · LIMITED PARTNER, PORTFOLIO MANAGER · 10–25%
  • ListedJAMES, CHRISTOPHER, MEDLOCK · LIMITED PARTNER, CIO, PORTFOLIO MANAGER · 25–50% · control person
  • ListedJAMES, CHRISTOPHER, MEDLOCK · M/M · 75% or more · indirect via PARTNER FUND MANAGEMENT GP, L.P.; PARTNER INVESTMENT MANAGEMENT GP, LLC; PARTNER ADVISORY SERVICES GP, LLC · control person
  • ListedMOORE, ERIC, TODD · LIMITED PARTNER, CFO · Less than 5% · control person
  • ListedPARTNER ADVISORY SERVICES GP, LLC · GENERAL PARTNER, PARTNER ADVISORY SERVICES, L.P. · Less than 5% · control person
  • ListedPARTNER FUND MANAGEMENT GP, LLC · GENERAL PARTNER, PARTNER FUND MANAGEMENT, L.P. · Less than 5% · control person
  • ListedPARTNER INVESTMENT MANAGEMENT GP, LLC · GENERAL PARTNER, PARTNER INVESTMENT MANAGEMENT, L.P. · Less than 5% · control person
  • ListedSADOW, DARIN, SCOTT · CCO · Less than 5%
  • ListedSEGURITAN, FREDERICK, ANTHONY · LIMITED PARTNER · 5–10%
  • ListedSUMME, KIMBERLY, ANNE · LIMITED PARTNER, COO, GENERAL COUNSEL · Less than 5%
  • ListedTARANTINO, KENN, RICHARD · LIMITED PARTNER · 5–10%

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

Top Adds (vs prior quarter)

Show all 40 →

Top Trims

Show all 20 →

PFM Health Sciences, LP Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 ASCENDIS PHARMA A/S ASND K08588103 $62.2M 5.34% 233,171 SH
2 AXSOME THERAPEUTICS INC. AXSM 05464T104 $53.8M 4.61% 219,596 SH
3 ELI LILLY & CO LLY 532457108 $47.1M 4.04% 39,258 SH
4 JAZZ PHARMACEUTICALS PLC JAZZ G50871105 $38.7M 3.32% 160,768 SH
5 HUMANA INC HUM 444859102 $37.5M 3.22% 94,375 SH
6 UNITEDHEALTH GROUP INC UNH 91324P102 $36.7M 3.15% 88,276 SH
7 NEUROCRINE BIOSCIENCES INC NBIX 64125C109 $36.0M 3.09% 213,407 SH
8 INHIBRX BIOSCIENCES INC INBX 45720N103 $29.2M 2.51% 308,385 SH
9 UNITED THERAPEUTICS CORP DEL UTHR 91307C102 $27.1M 2.32% 49,991 SH
10 REVOLUTION MEDICINES INC RVMD 76155X100 $26.8M 2.30% 143,222 SH
11 ICON PUB LTD CO ICLR G4705A100 $23.7M 2.03% 136,482 SH
12 TENET HEALTHCARE CORP THC 88033G407 $23.7M 2.03% 126,572 SH
13 EDWARDS LIFESCIENCES CORP EW 28176E108 $22.7M 1.94% 250,453 SH
14 WATERS CORP WAT 941848103 $22.4M 1.93% 59,825 SH
15 PENUMBRA INC PEN 70975L107 $19.0M 1.63% 60,221 SH
16 BRIDGEBIO PHARMA INC BBIO 10806X102 $18.9M 1.62% 253,358 SH
17 STRYKER CORPORATION SYK 863667101 $17.8M 1.53% 56,637 SH
18 METTLER TOLEDO INTERNATIONAL MTD 592688105 $17.0M 1.46% 13,344 SH
19 INDIVIOR PHARMACEUTICALS INC SUPN 45579U109 $16.5M 1.41% 401,208 SH
20 MERCK & CO INC MRK 58933Y105 $16.3M 1.40% 127,118 SH
21 CYTOKINETICS INC CYTK 23282W605 $16.3M 1.40% 191,686 SH
22 LANTHEUS HLDGS INC LNTH 516544103 $16.2M 1.39% 146,403 SH
23 CENTENE CORP DEL CNC 15135B101 $16.0M 1.37% 248,867 SH
24 COOPER COS INC COO 216648501 $15.8M 1.36% 220,890 SH
25 MADRIGAL PHARMACEUTICALS INC MDGL 558868105 $15.7M 1.35% 29,313 SH
26 ACADIA HEALTHCARE COMPANY IN ACHC 00404A109 $15.5M 1.33% 524,934 SH
27 ORUKA THERAPEUTICS INC ORKA 687604108 $15.1M 1.30% 158,825 SH
28 OSCAR HEALTH INC OSCR 687793109 $14.8M 1.27% 519,016 SH
29 THERMO FISHER SCIENTIFIC INC TMO 883556102 $14.3M 1.23% 28,496 SH
30 CVS HEALTH CORP CVS 126650100 $14.2M 1.22% 137,457 SH
31 MERIT MED SYS INC MMSI 589889104 $13.7M 1.17% 197,038 SH
32 PRAXIS PRECISION MEDICINES I PRAX 74006W207 $12.9M 1.11% 38,575 SH
33 CELLDEX THERAPEUTICS INC NEW CLDX 15117B202 $12.8M 1.09% 342,751 SH
34 NOVO-NORDISK A S NVO 670100205 $12.7M 1.09% 265,016 SH
35 INTEGER HLDGS CORP ITGR 45826H109 $11.8M 1.02% 126,669 SH
36 DIANTHUS THERAPEUTICS INC DNTH 252828108 $11.8M 1.01% 121,222 SH
37 DEFINIUM THERAPEUTICS INC DFTX 24477V105 $11.7M 1.01% 249,020 SH
38 GILEAD SCIENCES INC GILD 375558103 $11.5M 0.98% 90,858 SH
39 RHYTHM PHARMACEUTICALS INC RYTM 76243J105 $11.3M 0.97% 101,550 SH
40 SCHEIN HENRY INC HSIC 806407102 $11.2M 0.96% 134,423 SH
41 ARROWHEAD PHARMACEUTICALS IN ARWR 04280A100 $10.7M 0.92% 131,667 SH
42 TANGO THERAPEUTICS INC TNGX 87583X109 $10.2M 0.87% 326,047 SH
43 TELEFLEX INCORPORATED TFX 879369106 $10.1M 0.87% 79,708 SH
44 VIKING THERAPEUTICS INC VKTX 92686J106 $10.0M 0.85% 255,330 SH
45 BRIGHTSPRING HEALTH SVCS INC BTSG 10950A106 $9.9M 0.85% 141,914 SH
46 VERA THERAPEUTICS INC VERA 92337R101 $9.6M 0.83% 224,289 SH
47 ROIVANT SCIENCES LTD ROIV G76279101 $9.5M 0.81% 268,008 SH
48 CG ONCOLOGY INC CGON 156944100 $9.1M 0.78% 128,286 SH
49 AMNEAL PHARMACEUTICALS INC AMRX 03168L105 $8.3M 0.71% 480,715 SH
50 EUPRAXIA PHARMACEUTICALS INC EPRX 29842P105 $8.0M 0.69% 1,210,661 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $1.17B 98 0001442756-26-000006
2026-03-31 2026-05-15 $1.10B 83 0001442756-26-000002
2025-12-31 2026-02-17 $1.00B 78 0001442756-26-000001
2025-09-30 2025-11-14 $1.30B 72 0001442756-25-000007
Filer Information
Address
50 CALIFORNIA STREET
SUITE 2650
SAN FRANCISCO, CA 94111
Phone
(415) 281-1000
Filing Manager
PFM Health Sciences, LP
SAN FRANCISCO, CA
Signatory
Darren Mooney
Chief Compliance Officer